chr1-156924963-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144702.3(LRRC71):āc.541A>Gā(p.Lys181Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000214 in 1,399,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144702.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC71 | NM_144702.3 | c.541A>G | p.Lys181Glu | missense_variant | 5/15 | ENST00000337428.8 | NP_653303.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC71 | ENST00000337428.8 | c.541A>G | p.Lys181Glu | missense_variant | 5/15 | 1 | NM_144702.3 | ENSP00000336661.7 | ||
LRRC71 | ENST00000490146.5 | n.521A>G | non_coding_transcript_exon_variant | 6/16 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000641 AC: 1AN: 155986Hom.: 0 AF XY: 0.0000121 AC XY: 1AN XY: 82692
GnomAD4 exome AF: 0.00000214 AC: 3AN: 1399400Hom.: 0 Cov.: 32 AF XY: 0.00000290 AC XY: 2AN XY: 690218
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.541A>G (p.K181E) alteration is located in exon 5 (coding exon 5) of the LRRC71 gene. This alteration results from a A to G substitution at nucleotide position 541, causing the lysine (K) at amino acid position 181 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at